Indication

Anti-muscle-specific tyrosine kinase (MuSK) antibody positive generalized myasthenia gravis

Anti-muscle-specific tyrosine kinase (MuSK) antibody positive generalized myasthenia gravis is a rare, distinct autoimmune subtype of generalized myasthenia gravis affecting the peripheral nervous system and neuromuscular junction. Read more about Anti-muscle-specific tyrosine kinase (MuSK) antibody positive generalized myasthenia gravis

4 drugs 4 manufacturers

Advertisement

Drugs that treat it

Common Anti-muscle-specific tyrosine kinase (MuSK) antibody positive generalized myasthenia gravis therapies.

Showing 1–4 of 4 drugs

UPLIZNA (inebilizumab-cdon)

ANTINEOPLASTIC MONOCLONAL ANTIBODIES·NEUROMYELITIS OPTICA SPECTRUM DISORDER WITH ANTI-AQUAPORIN-4 (AQP4) ANTIBODIES·+3
HORIZON/AMGEN
Filter & compare in the drug finder →Opens the drug finder with Anti-muscle-specific tyrosine kinase (MuSK) antibody positive generalized myasthenia gravis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Anti-muscle-specific tyrosine kinase (MuSK) antibody positive generalized myasthenia gravis.

Anti-muscle-specific tyrosine kinase (MuSK) antibody positive generalized myasthenia gravis is a rare, distinct autoimmune subtype of generalized myasthenia gravis affecting the peripheral nervous system and neuromuscular junction.

It is mediated predominantly by pathogenic IgG4 autoantibodies directed against MuSK, a receptor essential for agrin-mediated acetylcholine receptor clustering and postsynaptic structural integrity.

Unlike typical acetylcholine receptor-associated disease, this form demonstrates a strong female predominance and is clinically characterized by severe, rapidly progressive muscle weakness that preferentially involves the bulbar, facial, neck, and respiratory musculature, frequently carrying a high risk of life-threatening myasthenic crisis and muscle atrophy.

Personalize your experience

Follow Anti-muscle-specific tyrosine kinase (MuSK) antibody positive generalized myasthenia gravis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it